"Designing Growth Strategies is in our DNA"

Asia Pacific Human Insulin Market Size, Share & COVID-19 Impact Analysis, By Type (Analog Insulin and Traditional Insulin), By Diabetes Type (Diabetes 1 and Diabetes 2), By Distribution Channel (Hospital Pharmacy and Retail & Online Pharmacy), and Regional Forecast, 2023-2030

Last Updated: February 17, 2025 | Format: CLOUD | Report ID: FBI107468

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Pipeline Analysis, By Key Players
    2. Pricing Analysis, By Key Countries, 2022
    3. Prevalence of Diabetes, By Key Countries, 2022
    4. Brand Analysis – By Key Countries
    5. Key Market Strategies, By Key Players
    6. Overview of Regulatory Scenario – For Key Countries
    7. Impact of COVID-19 on the Market
  5. Asia Pacific Human Insulin Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Type
      1. Analogue Insulin
        1. Long-acting
        2. Fast-acting
        3. Premix
      2. Traditional Human Insulin
        1. Long-acting
        2. Short-acting
        3. Fast-acting
        4. Premix
    2. Market Analysis, Insights and Forecast – By Diabetes Type
      1. Diabetes Type 1
      2. Diabetes Type 2
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail & Online Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. China
        1. By Diabetes Type
      2. Japan
        1. By Diabetes Type
      3. India
        1. By Diabetes Type
      4. Australia
        1. By Diabetes Type
      5. Southeast Asia
        1. By Diabetes Type
      6. Rest of Asia Pacific
        1. By Diabetes Type
  6. Competitive Analysis
    1. Asia Pacific Market Share Analysis (2022)
    2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
      1. Novo Nordisk A/S
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      2. Eli Lilly and Company
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      3. Sanofi
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      4. WOCKHARDT
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      5. Biocon
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      6. Lupin
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      7. Eris Lifesciences Ltd
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      8. Tonghua Dongbao Pharmaceutical Co., Ltd.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      9. Gan & Lee Pharmaceuticals Co. Ltd
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      10. The United Laboratories International Holdings Limited
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      11. Other Prominent Players
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
Read Less

Figure 1:  Asia Pacific Human Insulin Market Value (USD billion), by Type, 2022 & 2030

Figure 2:  Asia Pacific Human Insulin Market Value Share (%), by Type, 2022

Figure 3:  Asia Pacific Human Insulin Market Value (USD billion), by Diabetes Type, 2022 & 2030

Figure 4:  Asia Pacific Human Insulin Market Value Share (%), by Diabetes Type, 2022

Figure 5:  Asia Pacific Human Insulin Market Value (USD billion), by Distribution Channel, 2022 & 2030

Figure 6:  Asia Pacific Human Insulin Market Value Share (%), by Distribution Channel, 2022

Figure 7:  Asia Pacific Human Insulin Market Value (USD billion), By Country/ Sub-region, 2022 & 2030

Figure 8:  Asia Pacific Human Insulin Market Value Share (%), By Country/ Sub-region, 2022

Figure 9:  Asia Pacific Human Insulin Market Share (%), By Company, 2022

Table 1:  Asia Pacific Human Insulin Market Revenue (USD billion) Forecast, by Type, 2019-2030

Table 2:  Asia Pacific Human Insulin Market Revenue (USD billion) Forecast, by Diabetes Type, 2019-2030

Table 3:  Asia Pacific Human Insulin Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2030

Table 4:  Asia Pacific Human Insulin Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2030

Table 5:  China Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2019-2030

Table 6:  Japan Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2019-2030

Table 7:  India Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2019-2030

Table 8:  Australia Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2019-2031

Table 9:  Southeast Asia Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2019-2031

Table 10:  Rest of Asia Pacific Human Insulin Market Revenue (USD billion) Forecast, By Diabetes Type, 2019-2031

Asia Pacific Human Insulin Market Size, Share and Global Industry Trend Forecast till 2030
  • 2019-2030
  • 2022
  • 2019-2021
  • 109
Consulting Services
    How will you benefit from our consulting services ?